1 - 25 of 27 results for author:"Osinska H." in Literature citations
Results Customize
› Repeat search in UniProtKB (3)
| A thrombospondin-dependent pathway for a protective ER stress response. Lynch J.M., Maillet M., Vanhoutte D., Schloemer A., Sargent M.A., Blair N.S., Lynch K.A., Okada T., Aronow B.J., Osinska H. et al. Cell 149:1257-1268(2012) · Mapped (4) |
| The human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na/K-ATPase. Haghighi K., Pritchard T., Bossuyt J., Waggoner J.R., Yuan Q., Fan G.C., Osinska H., Anjak A., Rubinstein J., Robbins J. et al. J. Mol. Cell. Cardiol. 52:773-782(2012) · Mapped (3) |
| A critical function for Ser-282 in cardiac Myosin binding protein-C phosphorylation and cardiac function. Sadayappan S., Gulick J., Osinska H., Barefield D., Cuello F., Avkiran M., Lasko V.M., Lorenz J.N., Maillet M., Martin J.L. et al. Circ. Res. 109:141-150(2011) · Mapped (6) |
| Elastin haploinsufficiency results in progressive aortic valve malformation and latent valve disease in a mouse model. Hinton R.B., Adelman-Brown J., Witt S., Krishnamurthy V.K., Osinska H., Sakthivel B., James J.F., Li D.Y., Narmoneva D.A., Mecham R.P. et al. Circ. Res. 107:549-557(2010) · Mapped (1) |
| Heart-specific deletion of CnB1 reveals multiple mechanisms whereby calcineurin regulates cardiac growth and function. Maillet M., Davis J., Auger-Messier M., York A., Osinska H., Piquereau J., Lorenz J.N., Robbins J., Ventura-Clapier R., Molkentin J.D. J. Biol. Chem. 285:6716-6724(2010) · Mapped (3) |
| Role of ERK1/2 signaling in congenital valve malformations in Noonan syndrome. Krenz M., Gulick J., Osinska H.E., Colbert M.C., Molkentin J.D., Robbins J. Proc. Natl. Acad. Sci. U.S.A. 105:18930-18935(2008) · Mapped (42) |
| Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Millay D.P., Sargent M.A., Osinska H., Baines C.P., Barton E.R., Vuagniaux G., Sweeney H.L., Robbins J., Molkentin J.D. Nat. Med. 14:442-447(2008) · Mapped (18) |
| Role of the acidic N' region of cardiac troponin I in regulating myocardial function. Sadayappan S., Finley N., Howarth J.W., Osinska H., Klevitsky R., Lorenz J.N., Rosevear P.R., Robbins J. FASEB J. 22:1246-1257(2008) · Mapped (2) |
| Distribution and structure-function relationship of myosin heavy chain isoforms in the adult mouse heart. Krenz M., Sadayappan S., Osinska H.E., Henry J.A., Beck S., Warshaw D.M., Robbins J. J. Biol. Chem. 282:24057-24064(2007) · Mapped (11) |
| Cardiomyocyte degeneration with calpain deficiency reveals a critical role in protein homeostasis. Galvez A.S., Diwan A., Odley A.M., Hahn H.S., Osinska H., Melendez J.G., Robbins J., Lynch R.A., Marreez Y., Dorn G.W. Circ. Res. 100:1071-1078(2007) · Mapped (7) |
| Cardiac myosin binding protein C phosphorylation is cardioprotective. Sadayappan S., Osinska H., Klevitsky R., Lorenz J.N., Sargent M., Molkentin J.D., Seidman C.E., Seidman J.G., Robbins J. Proc. Natl. Acad. Sci. U.S.A. 103:16918-16923(2006) · Mapped (17) |
| Mitochondrial dysfunction and apoptosis underlie the pathogenic process in alpha-B-crystallin desmin-related cardiomyopathy. Maloyan A., Sanbe A., Osinska H., Westfall M., Robinson D., Imahashi K., Murphy E., Robbins J. Circulation 112:3451-3461(2005) · Mapped (2) |
| Cardiac myosin-binding protein-C phosphorylation and cardiac function. Sadayappan S., Gulick J., Osinska H., Martin L.A., Hahn H.S., Dorn G.W., Klevitsky R., Seidman C.E., Seidman J.G., Robbins J. Circ. Res. 97:1156-1163(2005) · Mapped (6) |
| Reversal of amyloid-induced heart disease in desmin-related cardiomyopathy. Sanbe A., Osinska H., Villa C., Gulick J., Klevitsky R., Glabe C.G., Kayed R., Robbins J. Proc. Natl. Acad. Sci. U.S.A. 102:13592-13597(2005) · Mapped (2) |
| Transgenic rabbit model for human troponin I-based hypertrophic cardiomyopathy. Sanbe A., James J., Tuzcu V., Nas S., Martin L., Gulick J., Osinska H., Sakthivel S., Klevitsky R., Ginsburg K.S. et al. Circulation 111:2330-2338(2005) · Mapped (4) |
| Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Baines C.P., Kaiser R.A., Purcell N.H., Blair N.S., Osinska H., Hambleton M.A., Brunskill E.W., Sayen M.R., Gottlieb R.A., Dorn G.W. et al. Nature 434:658-662(2005) · UniProtKB (1) |
| Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. Sanbe A., Osinska H., Saffitz J.E., Glabe C.G., Kayed R., Maloyan A., Robbins J. Proc. Natl. Acad. Sci. U.S.A. 101:10132-10136(2004) · Mapped (2) |
| NFATc3 and NFATc4 are required for cardiac development and mitochondrial function. Bushdid P.B., Osinska H., Waclaw R.R., Molkentin J.D., Yutzey K.E. Circ. Res. 92:1305-1313(2003) · Mapped (16) |
| Analysis of myosin heavy chain functionality in the heart. Krenz M., Sanbe A., Bouyer-Dalloz F., Gulick J., Klevitsky R., Hewett T.E., Osinska H.E., Lorenz J.N., Brosseau C., Federico A. et al. J. Biol. Chem. 278:17466-17474(2003) · UniProtKB (1) |
| Midgestational lethality in mice lacking the parathyroid hormone (PTH)/PTH-related peptide receptor is associated with abrupt cardiomyocyte death. Qian J., Colbert M.C., Witte D., Kuan C.Y., Gruenstein E., Osinska H., Lanske B., Kronenberg H.M., Clemens T.L. Endocrinology 144:1053-1061(2003) · Mapped (2) |
| Ischemic protection and myofibrillar cardiomyopathy: dose-dependent effects of in vivo deltaPKC inhibition. Hahn H.S., Yussman M.G., Toyokawa T., Marreez Y., Barrett T.J., Hilty K.C., Osinska H., Robbins J., Dorn G.W. Circ. Res. 91:741-748(2002) · Mapped (11) |
| Increased myocardial Rab GTPase expression: a consequence and cause of cardiomyopathy. Wu G., Yussman M.G., Barrett T.J., Hahn H.S., Osinska H., Hilliard G.M., Wang X., Toyokawa T., Yatani A., Lynch R.A. et al. Circ. Res. 89:1130-1137(2001) · Mapped (7) |
| Proinflammatory consequences of transgenic fas ligand expression in the heart. Nelson D.P., Setser E., Hall D.G., Schwartz S.M., Hewitt T., Klevitsky R., Osinska H., Bellgrau D., Duke R.C., Robbins J. J. Clin. Invest. 105:1199-1208(2000) · Mapped (3) |
| In vivo modeling of myosin binding protein C familial hypertrophic cardiomyopathy. Yang Q., Sanbe A., Osinska H., Hewett T.E., Klevitsky R., Robbins J. |
| Transgenic over-expression of a motor protein at high levels results in severe cardiac pathology. James J., Osinska H., Hewett T.E., Kimball T., Klevitsky R., Witt S., Hall D.G., Gulick J., Robbins J. Transgenic Res. 8:9-22(1999) · Mapped (2) |